Listing 3 - Actual negotiations

Indication:

Multiple Myeloma

Indication:

Multiple Myeloma

Indication:

Multiple Myeloma (newly diagnosed)

Indication:

High-risk Neuroblastoma in patients in their first relapse or determination of refractory disease, in combination with irinotecan, temozolomide, and granulocyte macrophage colony-stimulating factor

Indication:

Hyperkalemia

Indication:

Carcinoma of the esophagus or HER-2 negative gastroesophageal junction adenocarcinoma, locally advanced unresectable or metastatic, in combination with platinum and fluoropyrimidine based chemotherapy, in adult patients (First-line treatment)

Indication:

Extensive stage small cell lung cancer (ES-SCLC), first-line treatment, in combination with a platinum-based chemotherapy and etoposide

Indication:

Diabetes Mellitus, Type 1 & 2

Indication:

Chronic fibrosing interstitial lung diseases

Indication:

Spinal Muscular Atrophy